BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 36280389)

  • 21. Osteopenia is associated with wasting in pancreatic adenocarcinoma and predicts survival after surgery.
    Cameron ME; Underwood PW; Williams IE; George TJ; Judge SM; Yarrow JF; Trevino JG; Judge AR
    Cancer Med; 2022 Jan; 11(1):50-60. PubMed ID: 34791809
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Noncoding RNAs as potential biomarkers to predict the outcome in pancreatic cancer.
    Jin K; Luo G; Xiao Z; Liu Z; Liu C; Ji S; Xu J; Liu L; Long J; Ni Q; Yu X
    Drug Des Devel Ther; 2015; 9():1247-55. PubMed ID: 25750521
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
    Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
    World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inflammation and Wasting of Skeletal Muscles in Kras-p53-Mutant Mice with Intraepithelial Neoplasia and Pancreatic Cancer-When Does Cachexia Start?
    Hildebrandt W; Keck J; Schmich S; Bonaterra GA; Wilhelm B; Schwarzbach H; Eva A; Bertoune M; Slater EP; Fendrich V; Kinscherf R
    Cells; 2022 May; 11(10):. PubMed ID: 35626644
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long non‑coding RNA PCED1B‑AS1 promotes pancreatic ductal adenocarcinoma progression by regulating the miR‑411‑3p/HIF‑1α axis.
    Zhang Y; Ma H; Chen C
    Oncol Rep; 2021 Jul; 46(1):. PubMed ID: 34036383
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long non-coding RNAs expressed in pancreatic ductal adenocarcinoma and lncRNA BC008363 an independent prognostic factor in PDAC.
    Li J; Liu D; Hua R; Zhang J; Liu W; Huo Y; Cheng Y; Hong J; Sun Y
    Pancreatology; 2014; 14(5):385-90. PubMed ID: 25200694
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LncRNA PWAR6 regulates proliferation and migration by epigenetically silencing YAP1 in tumorigenesis of pancreatic ductal adenocarcinoma.
    Huang S; Li Y; Hu J; Li L; Liu Z; Guo H; Jiang B; Chen J; Li J; Xiang X; Deng J; Xiong J
    J Cell Mol Med; 2021 May; 25(9):4275-4286. PubMed ID: 33834618
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long noncoding RNA TP53TG1 promotes pancreatic ductal adenocarcinoma development by acting as a molecular sponge of microRNA-96.
    Zhang Y; Yang H; Du Y; Liu P; Zhang J; Li Y; Shen H; Xing L; Xue X; Chen J; Zhang X
    Cancer Sci; 2019 Sep; 110(9):2760-2772. PubMed ID: 31325400
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circular RNA ciRS-7 promotes the proliferation and metastasis of pancreatic cancer by regulating miR-7-mediated EGFR/STAT3 signaling pathway.
    Liu L; Liu FB; Huang M; Xie K; Xie QS; Liu CH; Shen MJ; Huang Q
    Hepatobiliary Pancreat Dis Int; 2019 Dec; 18(6):580-586. PubMed ID: 30898507
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-coding RNAs in pancreatic cancer: challenges and opportunities for clinical application.
    Taucher V; Mangge H; Haybaeck J
    Cell Oncol (Dordr); 2016 Aug; 39(4):295-318. PubMed ID: 27060060
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phases of Metabolic and Soft Tissue Changes in Months Preceding a Diagnosis of Pancreatic Ductal Adenocarcinoma.
    Sah RP; Sharma A; Nagpal S; Patlolla SH; Sharma A; Kandlakunta H; Anani V; Angom RS; Kamboj AK; Ahmed N; Mohapatra S; Vivekanandhan S; Philbrick KA; Weston A; Takahashi N; Kirkland J; Javeed N; Matveyenko A; Levy MJ; Mukhopadhyay D; Chari ST
    Gastroenterology; 2019 May; 156(6):1742-1752. PubMed ID: 30677401
    [TBL] [Abstract][Full Text] [Related]  

  • 32. AKT1 and SELP polymorphisms predict the risk of developing cachexia in pancreatic cancer patients.
    Avan A; Avan A; Le Large TY; Mambrini A; Funel N; Maftouh M; Ghayour-Mobarhan M; Cantore M; Boggi U; Peters GJ; Pacetti P; Giovannetti E
    PLoS One; 2014; 9(9):e108057. PubMed ID: 25238546
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MEF2c-Dependent Downregulation of Myocilin Mediates Cancer-Induced Muscle Wasting and Associates with Cachexia in Patients with Cancer.
    Judge SM; Deyhle MR; Neyroud D; Nosacka RL; D'Lugos AC; Cameron ME; Vohra RS; Smuder AJ; Roberts BM; Callaway CS; Underwood PW; Chrzanowski SM; Batra A; Murphy ME; Heaven JD; Walter GA; Trevino JG; Judge AR
    Cancer Res; 2020 May; 80(9):1861-1874. PubMed ID: 32132110
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Visceral adipose tissue remodeling in pancreatic ductal adenocarcinoma cachexia: the role of activin A signaling.
    Xu PC; You M; Yu SY; Luan Y; Eldani M; Caffrey TC; Grandgenett PM; O'Connell KA; Shukla SK; Kattamuri C; Hollingsworth MA; Singh PK; Thompson TB; Chung S; Kim SY
    Sci Rep; 2022 Jan; 12(1):1659. PubMed ID: 35102236
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long noncoding RNA DLEU1 aggravates pancreatic ductal adenocarcinoma carcinogenesis via the miR-381/CXCR4 axis.
    Gao S; Cai Y; Zhang H; Hu F; Hou L; Xu Q
    J Cell Physiol; 2019 May; 234(5):6746-6757. PubMed ID: 30382579
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Role of lncRNAs in the Stem Phenotype of Pancreatic Ductal Adenocarcinoma.
    Melendez-Zajgla J; Maldonado V
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34203589
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel long non-coding RNA ENST00000480739 suppresses tumour cell invasion by regulating OS-9 and HIF-1α in pancreatic ductal adenocarcinoma.
    Sun YW; Chen YF; Li J; Huo YM; Liu DJ; Hua R; Zhang JF; Liu W; Yang JY; Fu XL; Yan T; Hong J; Cao H
    Br J Cancer; 2014 Nov; 111(11):2131-41. PubMed ID: 25314054
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of long non-coding RNA expression profiles in pancreatic ductal adenocarcinoma.
    Fu XL; Liu DJ; Yan TT; Yang JY; Yang MW; Li J; Huo YM; Liu W; Zhang JF; Hong J; Hua R; Chen HY; Sun YW
    Sci Rep; 2016 Sep; 6():33535. PubMed ID: 27628540
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long non-coding RNA LOC389641 promotes progression of pancreatic ductal adenocarcinoma and increases cell invasion by regulating E-cadherin in a TNFRSF10A-related manner.
    Zheng S; Chen H; Wang Y; Gao W; Fu Z; Zhou Q; Jiang Y; Lin Q; Tan L; Ye H; Zhao X; Luo Y; Li G; Ye L; Liu Y; Li W; Li Z; Chen R
    Cancer Lett; 2016 Feb; 371(2):354-65. PubMed ID: 26708505
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long non-coding RNA CERS6-AS1 facilitates the oncogenicity of pancreatic ductal adenocarcinoma by regulating the microRNA-15a-5p/FGFR1 axis.
    Yun Z; Meng F; Li S; Zhang P
    Aging (Albany NY); 2021 Feb; 13(4):6041-6054. PubMed ID: 33581689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.